106 310

Cited 3 times in

Signal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005-2016

DC Field Value Language
dc.contributor.author박민수-
dc.date.accessioned2020-12-01T17:12:50Z-
dc.date.available2020-12-01T17:12:50Z-
dc.date.issued2020-03-
dc.identifier.issn0513-5796-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/180172-
dc.description.abstractPurpose: We aimed to analyze the surveillance reports of adverse events (AEs) due to different types of pneumococcal vaccines, in addition to detecting and validating signals of pneumococcal vaccines by comparing AEs with labels. Materials and methods: We analyzed the percentages of AEs according to vaccine type [pneumococcal polysaccharide vaccines (PPSVs) and pneumococcal conjugate vaccines (PCVs)] in children and adults using data from the Korea Adverse Event Reporting System (KAERS) database from 2005 to 2016. A signal was defined as an AE that met all three indices of data mining: proportional reporting ratio (PRR), reporting odds ratio (ROR), and information component (IC). We validated the detected signals by calculating sensitivity, specificity, as well as positive and negative predictive values of the signals against label information. Results: Of the 39933 AE reports on vaccination, 5718 (7.0%) were related to pneumococcal vaccine. The most frequent AE after vaccination with PPSV was fever (23.9%) in children and injection-site reaction in adults. The most frequent AE after vaccination with PCV in children was pharyngitis (26.2%). In total, 13 AEs met all three indices for signal detection. Among these, hypotension, apathy, sepsis, and increased serum glutamic oxaloacetic transaminase level were not listed on vaccine labels. In validation analysis, PRR and ROR performed slightly better than IC for adults who were vaccinated with PPSVs. Conclusion: Overall, 13 new signals of PPSVs, including four signals not listed on the labels, were detected. Further research based on additional AE reports is required to confirm the validity of these signals for children.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherYonsei University-
dc.relation.isPartOfYONSEI MEDICAL JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAdolescent-
dc.subject.MESHAdverse Drug Reaction Reporting Systems*-
dc.subject.MESHChild-
dc.subject.MESHDatabases, Factual*-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHInfant-
dc.subject.MESHInfant, Newborn-
dc.subject.MESHMale-
dc.subject.MESHPneumococcal Vaccines / immunology*-
dc.subject.MESHPredictive Value of Tests-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHSensitivity and Specificity-
dc.subject.MESHSignal Processing, Computer-Assisted*-
dc.subject.MESHVaccination-
dc.subject.MESHVaccines, Conjugate / immunology-
dc.titleSignal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005-2016-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pediatrics (소아청소년과학교실)-
dc.contributor.googleauthorKwan Soo Kim-
dc.contributor.googleauthorIn Sun Oh-
dc.contributor.googleauthorHyun Jeong Kim-
dc.contributor.googleauthorInmyung Song-
dc.contributor.googleauthorMin Soo Park-
dc.contributor.googleauthorJu Young Shin-
dc.identifier.doi10.3349/ymj.2020.61.3.243-
dc.contributor.localIdA01468-
dc.relation.journalcodeJ02813-
dc.identifier.eissn1976-2437-
dc.identifier.pmid32102125-
dc.subject.keywordKAERS database-
dc.subject.keywordSignal detection-
dc.subject.keyworddata-mining-
dc.subject.keywordpneumococcal vaccines-
dc.contributor.alternativeNamePark, Min Soo-
dc.contributor.affiliatedAuthor박민수-
dc.citation.volume61-
dc.citation.number3-
dc.citation.startPage243-
dc.citation.endPage250-
dc.identifier.bibliographicCitationYONSEI MEDICAL JOURNAL, Vol.61(3) : 243-250, 2020-03-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.